New Frontiers in NSCLC: The Promise and Progress of HER2-Directed Therapies
25/11/2024
0:00
54:17
Are you aware of the new therapies revolutionizing the treatment armamentarium for patients with HER2-mutated disease?
Credit available for this activity expires: 11/25/2025
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001833?ecd=bdc_podcast_libsyn_mscpedu
Otros episodios de "Keeping Current CME"
No te pierdas ningún episodio de “Keeping Current CME”. Síguelo en la aplicación gratuita de GetPodcast.